| Name: | INTERPATH LABORATORY, INC. |
| Jurisdiction: | Idaho |
| Legal type: | Foreign Business Corporation |
| Status: | Active-Good Standing |
| Date of registration: | 29 Sep 1999 (26 years ago) |
| Financial Date End: | 30 Sep 2025 |
| Entity Number: | 399381 |
| Place of Formation: | OREGON |
| File Number: | 399381 |
| Principal Address: | PO BOX 1208 PENDLETON, OR 97801 |
| Mailing Address: | PO BOX 1208 PENDLETON, OR 97801-0780 |
| Name | Role | Address |
|---|---|---|
| COGENCY GLOBAL INC. | Agent | 1555 W SHORELINE DR, STE 100, BOISE, ID 83702 |
| Name | Role | Address | Appointed On | Resigned On |
|---|---|---|---|---|
| Garrett TK Kennedy | President | 2460 SW PERKINS AVE., PENDLETON, OR 97801 | 2023-09-11 | No data |
| Thomas M Kennedy | President | 2460 SW PERKINS AVE, PENDLETON, OR 97801 | 2020-08-06 | 2023-09-11 |
| Filing Name | Filing Number | Filing date |
|---|---|---|
| Annual Report | 0005842187 | 2024-08-05 |
| Annual Report | 0005397615 | 2023-09-11 |
| Registered Agent Name/Address Change (mass change) | 0005296286 | 2023-06-29 |
| Registered Agent Name/Address Change (mass change) | 0005005654 | 2022-12-02 |
| Annual Report | 0004854185 | 2022-08-09 |
| Registered Agent Name/Address Change (mass change) | 0004786105 | 2022-06-17 |
| Annual Report | 0004383276 | 2021-08-13 |
| Annual Report | 0003961720 | 2020-08-06 |
| Annual Report | 0003624286 | 2019-09-18 |
| Change of Registered Office/Agent/Both (by Entity) | 0003553044 | 2019-06-26 |
| Inspection Nr | Report ID | Date Opened | Site Address | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 346858202 | 1032500 | 2023-07-25 | 8660 WEST EMERALD STREET, BOISE, ID, 83704 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Type | Complaint |
| Activity Nr | 2050065 |
| Safety | Yes |
Violation Items
| Citation ID | 01001 |
| Citaton Type | Serious |
| Standard Cited | 19101030 C01 II A |
| Issuance Date | 2024-01-23 |
| Abatement Due Date | 2024-04-01 |
| Current Penalty | 6171.2 |
| Initial Penalty | 8816.0 |
| Final Order | 2024-02-13 |
| Nr Instances | 1 |
| Nr Exposed | 19 |
| Gravity | 5 |
| FTA Current Penalty | 0.0 |
| Citation text line | 29 CFR 1910.1030(c)(1)(ii)(A): The employer's Exposure Control Plan did not include the exposure determination required by 29 CFR 1910.1030(c)(2): (a) On or about July 25, 2023, and prior to; employees such as phlebotomists and medical technicians performed tasks including but not limited to blood draws, conducting laboratory tests on blood, bodily fluids, and tissue samples, exposing them to blood and other potentially infectious material. The employer had not identified and documented, in a list, job classifications and the respective tasks and procedures assigned to them, in which employees are reasonably anticipated to come into contact with blood or other potentially infectious material during the performance of their duties. |
| Citation ID | 01002A |
| Citaton Type | Serious |
| Standard Cited | 19101030 C01 IV A |
| Issuance Date | 2024-01-23 |
| Abatement Due Date | 2024-04-01 |
| Current Penalty | 6171.2 |
| Initial Penalty | 8816.0 |
| Final Order | 2024-02-13 |
| Nr Instances | 1 |
| Nr Exposed | 19 |
| Related Event Code (REC) | Complaint |
| Gravity | 5 |
| FTA Current Penalty | 0.0 |
| Citation text line | 29 CFR 1910.1030(c)(1)(iv)(A): The review and update of the exposure control plan did not reflect changes in technology that eliminate or reduce exposure to bloodborne pathogens: (a) On or about July 25,2023 and prior to; employees such as phlebotomists and medical technicians performed tasks including but not limited to blood draws, conducting laboratory tests on blood, bodily fluids, and tissue samples, exposing them to blood and other potentially infectious material. The employer did not review and document innovations in procedure and technological developments that eliminate or reduce exposure to bloodborne pathogens in a written exposure control plan. |
| Citation ID | 01002B |
| Citaton Type | Serious |
| Standard Cited | 19101030 C01 IV B |
| Issuance Date | 2024-01-23 |
| Abatement Due Date | 2024-04-01 |
| Current Penalty | 0.0 |
| Initial Penalty | 0.0 |
| Final Order | 2024-02-13 |
| Nr Instances | 1 |
| Nr Exposed | 19 |
| Related Event Code (REC) | Complaint |
| Gravity | 5 |
| FTA Current Penalty | 0.0 |
| Citation text line | 29 CFR 1910.1030(c)(1)(iv)(B): The review and update of the exposure control plan did not document annually consideration and implementation of appropriate commercially available and effective safer medical devices designed to eliminate or minimize occupational exposure: (a) On or about July 25,2023 and prior to; phlebotomists and medical technicians are exposed to blood or other potentially infectious material during the blood culture collection procedure when using a hypodermic syringe to directly puncture the rubber septum of a blood culture tube which is held in plastic tube racks. The employer failed to perform a thorough hazard assessment and document the feasibility and appropriateness for use of engineering controls before instituting its use. |
| Citation ID | 01002C |
| Citaton Type | Serious |
| Standard Cited | 19101030 C01 V |
| Issuance Date | 2024-01-23 |
| Abatement Due Date | 2024-04-01 |
| Current Penalty | 0.0 |
| Initial Penalty | 0.0 |
| Final Order | 2024-02-13 |
| Nr Instances | 1 |
| Nr Exposed | 19 |
| Related Event Code (REC) | Complaint |
| Gravity | 5 |
| FTA Current Penalty | 0.0 |
| Citation text line | 29 CFR 1910.1030(c)(1)(v): The employer, who is required to establish an Exposure Control Plan, did not solicit input from non-managerial employees responsible for direct patient care who are potentially exposed to injuries from contaminated sharps in the identification, evaluation and selection of effective engineering and work practice controls and did not document the solicitation in the Exposure Control Plan: a) On or about July 25,2023 and prior to; employees such as phlebotomists and medical technicians performed tasks including but not limited to blood draws, conducting laboratory tests on blood, bodily fluids, and tissue samples, exposing them to blood and other potentially infectious material. Request for input from non-managerial employees when evaluating and selecting safer devices and procedures was not documented in an Exposure Control Plan. |
| Docket Number | Nature of Suit | Filing Date | Disposition | |||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2400581 | Other Labor Litigation | 2024-12-04 | missing | |||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||
| Name | SU |
| Role | Plaintiff |
| Name | INTERPATH LABORATORY, INC. |
| Role | Defendant |
| Package ID | Category | Cause | Nature Of Suit | |||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| USCOURTS-idd-1_24-cv-00581 | Judicial Publications | 29:2601 Family Medical Leave Act | Other Labor Litigation | |||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
| Name | INTERPATH LABORATORY, INC. |
| Role | Defendant |
| Name | Julie A. Su |
| Role | Plaintiff |
Opinions
| Opinion ID | USCOURTS-idd-1_24-cv-00581-0 |
| Date | 2025-02-05 |
| Notes | LITIGATION ORDER AND NOTICE OF TELEPHONIC SCHEDULING CONFERENCE - The Court will conduct a telephonic scheduling conference on March 21, 2025, at 10:00 a.m. mountain time, (Boise chambers) for purpose of confirming the deadlines proposed by the parties in the joint LitigationPlan. Plaintiff must initiate the conference call by placing it to (208) 334-1026 and must have all appropriate parties on the line. On or before March 14, 2025, the parties must file with the Court the joint Litigation Plan and Discovery Plan. Signed by Judge David C. Nye. (caused to be mailed to non Registered Participants at the addresses listed on the Notice of Electronic Filing (NEF) by (lm) |
| View | View File |
Date of last update: 14 Mar 2025
Sources: Idaho Secretary of State
